5/26/2016

Adenosine Injection

Products Affected - Description

- Adenosine intravenous injection, West-Ward, 3 mg/mL, 2 mL vial, 10 count, NDC 00641-6113-10

Reason for the Shortage

- Astellas discontinued Adenoscan in April 2015. Adenoscan is used for diagnostic purposes as an adjunct to thallium-201 myocardial perfusion scintigraphy. Adenocard and generic adenosine products are labeled for use in paroxysmal supraventricular tachycardia.
- Sagent had adenosine vials on shortage due to increased demand.
- West-Ward has adenosine injection on shortage due to manufacturing delays.

Available Products

- Adenosine intravenous injection, Akorn, 3 mg/mL, 20 mL vial, 1 count, NDC 17478-0544-20
- Adenosine intravenous injection, Akorn, 3 mg/mL, 30 mL vial, 1 count, NDC 17478-0544-30
- Adenosine intravenous injection, Pfizer, 3 mg/mL, 20 mL vial, 25 count, NDC 00409-1932-01
- Adenosine intravenous injection, Pfizer, 3 mg/mL, 30 mL vial, 25 count, NDC 00409-1932-02
- Adenosine intravenous injection, Sagent, 3 mg/mL, 20 mL vial, 1 count, NDC 25021-0307-20
- Adenosine intravenous injection, Sagent, 3 mg/mL, 30 mL vial, 1 count, NDC 25021-0307-30
- Adenosine intravenous injection, Teva, 3 mg/mL, 20 mL vial, 1 count, NDC 00703-8776-01
- Adenosine intravenous injection, Teva, 3 mg/mL, 30 mL vial, 1 count, NDC 00703-8777-01
- Adenocard intravenous injection, Astellas, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 00469-8234-12
- Adenocard intravenous injection, Astellas, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 00469-8234-14
- Adenosine intravenous injection, Akorn, 3 mg/mL, 2 mL vial, 10 count, NDC 17478-0542-02
- Adenosine intravenous injection, Akorn, 3 mg/mL, 2 mL vial, 25 count, NDC 17478-0542-25
- Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL vial, 10 count, NDC 63323-0651-02
- Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL vial, 10 count, NDC 63323-0651-04
- Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 25021-0301-67
- Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL vial, 10 count, NDC 25021-0301-02
- Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 25021-0301-68
- Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL vial, 10 count, NDC 25021-0301-04

Estimated Resupply Dates

- West-Ward has adenosine 3 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
- All other marketed presentations are available.

Updated

Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 19, 2012 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.